Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Pseudoephedrine hydrochloride 60 mg oral tablet |
Is a |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Pseudoephedrine hydrochloride 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Pseudoephedrine hydrochloride 120mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Pseudoephedrine hydrochloride 120mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL/15mg/5mL/60mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/1mL/4mg/1mL/25mg/1mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/1mL/4mg/1mL/15mg/1mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Carbinoxamine maleate+pseudoephedrine hydrochloride 4mg/5mL/60mg/5mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Carbinoxamine maleate+pseudoephedrine hydrochloride 2mg/1mL/15mg/1mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Carbinoxamine maleate+pseudoephedrine hydrochloride 2mg/1mL/25mg/1mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Carbinoxamine maleate+pseudoephedrine hydrochloride 2mg/5mL/30mg/5mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Carbinoxamine maleate+pseudoephedrine hydrochloride 8mg/120mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Cetirizine hydrochloride+pseudoephedrine hydrochloride 5mg/120mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Fexofenadine hydrochloride+pseudoephedrine hydrochloride 60mg/120 mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/5mL 10mg/5mL 30mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL 15mg/5mL 60mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Brompheniramine maleate + hydrocodone bitartrate + pseudoephedrine hydrochloride 2mg/1.7mg/30mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Cetirizine hydrochloride + pseudoephedrine 5mg/120mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Chlorpheniramine maleate + methscopolamine nitrate + pseudoephedrine hydrochloride 8mg/2.5mg/120mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Chlorphenamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Codeine phosphate + pseudoephedrine hydrochloride + triprolidine hydrochloride 10mg/30mg/1.25mg liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Fexofenadine hydrochloride + pseudoephedrine hydrochloride 60mg/120mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Methscopolamine 2.5 mg and pseudoephedrine hydrochloride 120 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Pseudoephedrine hydrochloride 120 mg and terfenadine 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Pseudoephedrine hydrochloride 60 mg and triprolidine hydrochloride 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL 15mg/5mL 45mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL 30mg/5mL 60mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL/12.5mg/5mL/60mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 1mg/1mL/4mg/1mL/15mg/1mL drop |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Carbinoxamine maleate+pseudoephedrine hydrochloride 1mg/1mL/15mg/1mL drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Ibuprofen+pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Product containing methscopolamine and pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Product containing pseudoephedrine hydrochloride and terfenadine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Brompheniramine maleate + hydrocodone bitartrate + pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Brompheniramine maleate + pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Cetirizine hydrochloride+pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Product containing carbinoxamine maleate and pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Codeine phosphate + pseudoephedrine hydrochloride + triprolidine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Chlorpheniramine maleate + methscopolamine nitrate + pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Acrivastine+pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Pseudoephedrine hydrochloride + triprolidine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Fexofenadine hydrochloride+pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Pseudoephedrine hydrochloride 120mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely ibuprofen 200 milligram and pseudoephedrine 30 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely ibuprofen 300 milligram and pseudoephedrine 45 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Ibuprofen+pseudoephedrine 100mg/15mg oral 5mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Fexofenadine hydrochloride+pseudoephedrine hydrochloride 180mg/240mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Chlorpheniramine maleate + pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely paracetamol 500 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Product containing paracetamol and pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Brompheniramine maleate + pseudoephedrine hydrochloride 16mg/240mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Cetirizine hydrochloride + pseudoephedrine 5mg/120mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Ibuprofen 200 mg and pseudoephedrine 30 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
2 |
Pseudoephedrine hydrochloride 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
1 |
Pseudoephedrine hydrochloride 60 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
1 |
Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
1 |
Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
1 |
Chlorphenamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
1 |
Acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
1 |
Acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
1 |
Methscopolamine 2.5 mg and pseudoephedrine hydrochloride 120 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
2 |
Methscopolamine 2.5 mg and pseudoephedrine hydrochloride 120 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
2 |
Pseudoephedrine hydrochloride 120 mg and terfenadine 60 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
1 |
Pseudoephedrine hydrochloride 60 mg and triprolidine hydrochloride 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
1 |
Pseudoephedrine hydrochloride 60 mg and triprolidine hydrochloride 2.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
1 |
Chlorphenamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
2 |
Chlorphenamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
2 |
Pseudoephedrine hydrochloride 120 mg and terfenadine 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
2 |
Pseudoephedrine hydrochloride 120 mg and terfenadine 60 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely paracetamol 500 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely paracetamol 500 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
1 |
Cetirizine hydrochloride + pseudoephedrine 5mg/120mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Brompheniramine maleate + pseudoephedrine hydrochloride 16mg/240mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Carbinoxamine maleate+pseudoephedrine hydrochloride 8mg/120mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Chlorpheniramine maleate + methscopolamine nitrate + pseudoephedrine hydrochloride 8mg/2.5mg/120mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Fexofenadine hydrochloride+pseudoephedrine hydrochloride 60mg/120 mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Pseudoephedrine hydrochloride 120mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely pseudoephedrine hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely pseudoephedrine hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
1 |
Chlorphenamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
1 |
Acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
1 |
Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
2 |
Pseudoephedrine hydrochloride 60 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
1 |
Pseudoephedrine hydrochloride 60 mg and triprolidine hydrochloride 2.5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pseudoephedrine hydrochloride |
Inferred relationship |
Some |
1 |